Last reviewed · How we verify

aspirin，chinese herbs； — Competitive Intelligence Brief

aspirin，chinese herbs； (aspirin，chinese herbs；) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiplatelet agent with herbal adjunct. Area: Cardiovascular.

marketed Antiplatelet agent with herbal adjunct COX-1 (aspirin component); herbal targets not well-defined Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

aspirin，chinese herbs； (aspirin，chinese herbs；) — Guangzhou University of Traditional Chinese Medicine. A combination of aspirin and Chinese herbal ingredients that work together to reduce inflammation, inhibit platelet aggregation, and promote blood circulation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
aspirin，chinese herbs； TARGET aspirin，chinese herbs； Guangzhou University of Traditional Chinese Medicine marketed Antiplatelet agent with herbal adjunct COX-1 (aspirin component); herbal targets not well-defined

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiplatelet agent with herbal adjunct class)

  1. Guangzhou University of Traditional Chinese Medicine · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). aspirin，chinese herbs； — Competitive Intelligence Brief. https://druglandscape.com/ci/aspirin-chinese-herbs. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: